Definition of murine T helper cell determinants in the major capsid protein of human papillomavirus type 16

References

1. Banks L., Matlashewski G., Pim D., Churcher M., Roberts C., Crawford L. 1987; Expression of human papillomavirus type 6 and type 16 capsid proteins in bacteria and their antigenic characterization. Journal of General Virology 68:3081–3089
   [Google Scholar]
2. Barany G., Merrifield R. 1979; Solid phase peptide synthesis. In The Peptides pp. 1–284 Gross E., Meienhofer J. Edited by New York: Academic Press;
   [Google Scholar]
3. Brodersen I., Genner J., Brodthagen H. 1974; Tuberculin sensitivity in BCG-vaccinated children with common warts. Acta dermato-venereologica 54:291–292
   [Google Scholar]
4. Burnette W. W. 1981; ‘Western blotting’: electrophoretic transfer of proteins from sodium dodecyl sulfate-polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated Protein A. Analytical Biochemistry 112:195–203
   [Google Scholar]
5. Cason J., Patel D., Naylor J., Lunney D., Shepherd P. S., Best J. M., Mccance D. J. 1989; Identification of immunogenic regions of the major coat protein of human papillomavirus type 16 that contain type-restricted epitopes. Journal of General Virology 70:2973–2987
   [Google Scholar]
6. Chain B. M., Mccafferty I., Wallace G., Askenase P. W. 1987; Improvement of the in vitro T cell proliferation assay by a modified method that separates the antigen recognition and IL-2-dependent steps. Journal of Immunological Methods 99:221–228
   [Google Scholar]
7. Chretien J. H., Esswein J. G., Garagusi V. F. 1978; Decreased T cell levels in patients with warts. Archives of Dermatology 114:213–215
   [Google Scholar]
8. Cole S. T., Danos O. 1987; Nucleotide sequence and comparative analysis of the human papillomavirus type 18 genome. Journal of Molecular Biology 193:599–608
   [Google Scholar]
9. Cole S. T., Streek R. E. 1986; Genome organisation and nucleotide sequence of human papillomavirus type 33, which is associated with cervical cancer. Journal of Virology 58:991–995
   [Google Scholar]
10. Corradin G., Etlinger H. M., Chiller J. M. 1977; Lymphocyte specificity to protein antigens. I. Characterization of the antigen- induced in vitro T cell-dependent proliferative response with lymph node cells from primed mice. Journal of Immunology 119:1048–1053
    [Google Scholar]
11. Danos O., Katinka M., Yaniv M. 1982; Human papillomavirus la complete DNA sequence: a novel type of genome organisation among papovaviridae. EMBO Journal 1:231–236
    [Google Scholar]
12. Dartmann K., Schwarz E., Gissmann L., zur Hausen H. 1986; The nucleotide sequence and genome organisation of human papillomavirus type 11. Virology 151:124–130
    [Google Scholar]
13. de Villiers E.-M. 1989; Heterogeneity of the human papillomavirus group. Journal of Virology 63:4898–4903
    [Google Scholar]
14. Fuchs P. G., Iftner T., Weninger J., Pfister H. 1986; Epidermodysplasiaverruciformis-associated human papillomavirus 8: genomic sequence and comparative analysis. Journal of Virology 58:626–634
    [Google Scholar]
15. Galloway D. A., Jenison S. A. 1990; Characterization of the humoral immune response to genital papillomaviruses. Molecular Biology and Medicine 7:59–72
    [Google Scholar]
16. Gissmann L., Schwarz E. 1986; Persistence and expression of human papillomavirus DNA in genital cancer. In Papillomaviruses Ciba Foundation Symposium 120 pp. 190–197 Chichester: Wiley;
    [Google Scholar]
17. Iwatsuki K., Tagami M., Takigawa M., Yamada M. 1986; Plane warts under spontaneous regression. Immunopathologic study on cellular constituents leading to the inflammatory reaction. Archives of Dermatology 122:655–659
    [Google Scholar]
18. Laemmli U. K. 1970; Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature; London: 227680–685
    [Google Scholar]
19. Lutzner M. A., Orth G., Dutronquay V., Ducasse M.-F., Kreis H., Crosnier J. 1983; Detection of human papillomavirus type 5 DNA in skin cancers of an immunosuppressed renal allograft recipient. Lancet ii:422–424
    [Google Scholar]
20. Mclean C. S., Churcher M. J., Meinke J., Smith G. L., Higgins G., Stanley M., Minson A. C. 1990; Production and characterisation of a monoclonal antibody to human papillomavirus type 16 using a recombinant vaccinia virus. Journal of Clinical Pathology 43:488–492
    [Google Scholar]
21. Mahy B. W. J. 1985; Strategies of virus persistence. British Medical Bulletin 44:50–55
    [Google Scholar]
22. Morison W. L. 1975a; Viral warts, herpes simplex and herpes zoster in patients with secondary immune deficiencies and neoplasms. British Journal of Dermatology 92:625–630
    [Google Scholar]
23. Morison W. L. 1975b; Cell-mediated immune responses in patients with warts. British Journal of Dermatology 93:553–556
    [Google Scholar]
24. Osato T., Mizuno F., Fujiwara S., Koizumi S. 1986; Human Epstein-Barr virus and cancer. In Human Oncogenic Viruses. Molecular Analysis and Diagnosis pp. 185–211 Luderer A. A., Weetal H. H. Edited by CLifton, New Jersey: The Humana Press;
    [Google Scholar]
25. Patel D., Shepherd P. S., Naylor J. A., Mccance D. J. 1989; Reactivities of polyclonal and monoclonal antibodies raised to the major capsid protein of human papillomavirus type 16. Journal of General Virology 70:69–77
    [Google Scholar]
26. Remaut E., Stanssens P., Fiers W. 1981; Plasmid vectors for high-efficiency expression controlled by the p_L promoter of coliphage lambda. Gene 15:81–93
    [Google Scholar]
27. Rothbard J. B., Taylor W. R. 1988; A sequence pattern common to T cell epitopes. EMBO Journal 1:93–100
    [Google Scholar]
28. Schwarz E., Dürst M., Demankowski C., Latterman O., Zech R., Wolfsperger E., Suhai S., zur Hausen H. 1983; DNA sequence and genome organisation of human papillomavirus type 6b. EMBO Journal 2:2341–2348
    [Google Scholar]
29. Seedorf K., Krammer G., Dürst M., Suhai S., Rowekamp W. G. 1985; Human papillomavirus type 16 DNA sequence. Virology 145:181–185
    [Google Scholar]
30. Stanley M., Browne M. A., Appleby M., Minson A. C. 1989; Properties of a non-tumorigenic human cervical keratinocyte cell line. International Journal of Cancer 43:672–676
    [Google Scholar]
31. Strang G., Hickling J. K., Mcindoe G. A. J., Howland K., Wilkinson D., Ikeda H., Rothbard J. B. 1990; Human T cell responses to human papillomavirus type 16 LI and E6 synthetic peptides: identification of T cell determinants, HLA-DR restriction and virus type specificity. Journal of General Virology 71:423–431
    [Google Scholar]
32. Tagami H., Oku T., Iwatsuki K. 1985; Primary tissue culture of spontaneously regressing flat warts. In vitro attack by mononuclear cells against wart-derived epidermal cells. Cancer 55:2437–2441
    [Google Scholar]
33. Taylor W. R. 1988; Pattern matching methods in protein sequence comparison and structure prediction. Protein Engineering 2:77–86
    [Google Scholar]
34. Thivolet J., Viac J., Staquet M. J. 1982; Cell mediated immunity in wart infection. International Journal of Dermatology 21:94
    [Google Scholar]
35. Zachow K. R., Ostrow R. S., Faras A. J. 1987; Nucleotide sequence and genome organisation of human papillomavirus type 5. Virology 158:251–254
    [Google Scholar]
36. Zuckerman A. J., Howard C. R. 1979 In Hepatitis Viruses of Man pp. 114–129 New York & London: Academic Press;
    [Google Scholar]
37. zur Hausen H., Schneider A. 1987; The role of papillomavirus in human anogenital cancer. In The Papovaviridae: The Papillomaviruses pp. 245–263 Howley P. M., Salzman N. P. Edited by New York: Plenum Press;
    [Google Scholar]